Opportunities and challenges in nano-structure mediated drug delivery: where do we stand?
R Awasthi, I Pant, GT Kulkarni… - … : Recent Patents on …, 2016 - ingentaconnect.com
Background: An effective drug delivery system delivers the therapeutically active moieties at
the right time, rate and in a reproducible manner to effectively target sites for human …
the right time, rate and in a reproducible manner to effectively target sites for human …
[引用][C] Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
R Awasthi, I Pant, GT Kulkarni, IS Kikuchi, TJA Pinto… - ingentaconnect.com
In the present study, imatinib-loaded chitosan magnetic nanoparticles were formulated by
modified ionic gelation method applying central composite design. The magnetic and nano …
modified ionic gelation method applying central composite design. The magnetic and nano …
[引用][C] Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
R Awasthi, I Pant, GT Kulkarni… - Current …, 2016 - opus.lib.uts.edu.au
OPUS at UTS: Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where
Do We Stand? - Open Publications of UTS Scholars Skip navigation OPUS at UTS | Open …
Do We Stand? - Open Publications of UTS Scholars Skip navigation OPUS at UTS | Open …
[引用][C] Opportunities and challenges in Nano-structure mediated drug delivery: where do we stand?
R Awasthi, I Pant, GT Kulkarni, IS Kikuchi… - Current …, 2016 - repositorio.usp.br
ReP USP - Detalhe do registro: Opportunities and challenges in Nano-structure mediated drug
delivery: where do we stand? Home About USP Schools USP Schools Escola de Artes …
delivery: where do we stand? Home About USP Schools USP Schools Escola de Artes …